• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

睫状体上皮多形性腺癌:1例罕见病例的临床病理、免疫组化、超微结构、DNA倍体及比较基因组杂交分析

Pleomorphic adenocarcinoma of the ciliary epithelium: a clinicopathological, immunohistochemical, ultrastructural, DNA-ploidy and comparative genomic hybridization analysis of an unusual case.

作者信息

Nicolò M, Nicolò G, Zingirian M

机构信息

Department of Neurological and Visual Sciences, University of Genova, Italy.

出版信息

Eur J Ophthalmol. 2002 Jul-Aug;12(4):319-23. doi: 10.1177/112067210201200412.

DOI:10.1177/112067210201200412
PMID:12220004
Abstract

PURPOSE

To describe detailed phenotypic and genotypic analysis of a pleomorphic adenocarcinoma of the ciliary epithelium (CE).

CASE REPORT

An 86-year-old white woman developed an enlarging mass protruding from her previously eviscerated left eye 2 months postoperatively. Based on light and ultrastructural microscopy, the final diagnosis was a pleomorphic adenocarcinoma of the ciliary epithelium (CE).

DISCUSSION

Cell proliferation indices confirmed the unusually rapid growth rate of this tumor; the peridiploid DNA content might explain the relatively low incidence of distant metastases. An imbalance of the chromosome 6 was also found by Comparative Genomic Hybridization (CGH).

摘要

目的

描述睫状体上皮多形性腺癌的详细表型和基因型分析。

病例报告

一名86岁白人女性在左眼眼球摘除术后2个月,出现一个从手术眼突出且不断增大的肿块。基于光镜和超微结构显微镜检查,最终诊断为睫状体上皮多形性腺癌。

讨论

细胞增殖指数证实了该肿瘤异常快速的生长速度;亚二倍体DNA含量可能解释了远处转移相对较低的发生率。通过比较基因组杂交(CGH)还发现了6号染色体的不平衡。

相似文献

1
Pleomorphic adenocarcinoma of the ciliary epithelium: a clinicopathological, immunohistochemical, ultrastructural, DNA-ploidy and comparative genomic hybridization analysis of an unusual case.睫状体上皮多形性腺癌:1例罕见病例的临床病理、免疫组化、超微结构、DNA倍体及比较基因组杂交分析
Eur J Ophthalmol. 2002 Jul-Aug;12(4):319-23. doi: 10.1177/112067210201200412.
2
Adenoma of the nonpigmented ciliary epithelium.
Retina. 1994;14(5):452-6. doi: 10.1097/00006982-199414050-00011.
3
Pleomorphic adenocarcinomas of the ciliary epithelium. Immunohistochemical and ultrastructural features of 12 cases.
Ophthalmology. 1999 Jan;106(1):103-10. doi: 10.1016/S0161-6420(99)90024-6.
4
Pleomorphic adenocarcinoma of the ciliary body. Immunohistochemical and electron microscopic features.睫状体多形性腺癌。免疫组织化学及电镜特征
Ophthalmology. 1990 Jun;97(6):763-8. doi: 10.1016/s0161-6420(90)32522-8.
5
Adenocarcinoma of the nonpigmented ciliary epithelium: report of two cases with immunohistochemical findings.非色素睫状上皮腺癌:两例报告及免疫组化结果
Graefes Arch Clin Exp Ophthalmol. 2001 Nov;239(11):876-81. doi: 10.1007/s004170100353.
6
Adenocarcinoma of the ciliary body pigment epithelium in a child.一名儿童的睫状体色素上皮腺癌。
Arch Ophthalmol. 1984 Jan;102(1):100-3. doi: 10.1001/archopht.1984.01040030084042.
7
Adenoma of the nonpigmented ciliary epithelium.无色素睫状上皮腺瘤
Eur J Ophthalmol. 2006 Jul-Aug;16(4):630-3. doi: 10.1177/112067210601600424.
8
Adenoma of nonpigmented ciliary epithelium with smooth muscle differentiation.具有平滑肌分化的无色素睫状上皮腺瘤
Arch Ophthalmol. 1999 Jan;117(1):117-9. doi: 10.1001/archopht.117.1.117.
9
Acquired neoplasms of the nonpigmented ciliary epithelium (adenoma and adenocarcinoma).非色素性睫状体上皮获得性肿瘤(腺瘤和腺癌)。
Ophthalmology. 1996 Dec;103(12):2007-16. doi: 10.1016/s0161-6420(96)30393-x.
10
Cytomorphology of a mixed pigmented/nonpigmented pleomorphic adenoma of the ciliary body: a diagnostic pitfall in the evaluation of intraocular tumors.
Diagn Cytopathol. 1996 May;14(3):259-62. doi: 10.1002/(SICI)1097-0339(199604)14:3<259::AID-DC12>3.0.CO;2-K.

引用本文的文献

1
Aggressive Ciliary Body Adenocarcinoma with Bilateral Lung Metastases: Histological, Molecular, Genetic and Clinical Aspects.伴有双侧肺转移的侵袭性睫状体腺癌:组织学、分子、遗传学及临床特征
Ocul Oncol Pathol. 2019 Feb;5(2):79-84. doi: 10.1159/000487805. Epub 2018 May 7.